| REGEN-COV antibody combination and outcomes in outpatients with Covid-19 DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, J Xiao, ... New England Journal of Medicine 385 (23), e81, 2021 | 628 | 2021 |
| Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial TL Holland, AA Ginde, R Paredes, TA Murray, N Engen, G Grandits, ... The Lancet Respiratory Medicine 10 (10), 972-984, 2022 | 59 | 2022 |
| The association of baseline plasma SARS-CoV-2 nucleocapsid antigen level and outcomes in patients hospitalized with COVID-19 ACTIV-3/TICO Study Group Annals of internal medicine 175 (10), 1401-1410, 2022 | 39 | 2022 |
| Casirivimab and imdevimab for the treatment of hospitalized patients with COVID-19 S Somersan-Karakaya, E Mylonakis, VP Menon, JC Wells, S Ali, ... The Journal of infectious diseases 227 (1), 23-34, 2023 | 38 | 2023 |
| Efficacy and safety of ensovibep for adults hospitalized with COVID-19: a randomized controlled trial ACTIV-3/TICO Study Group* Annals of internal medicine 175 (9), 1266-1274, 2022 | 20 | 2022 |
| Clinical outcomes of adult patients hospitalized with COVID-19 after vaccination M Kalligeros, F Shehadeh, EK Mylona, M Kaczynski, S Kalagara, E Atalla, ... Tropical Medicine and Infectious Disease 6 (4), 175, 2021 | 15 | 2021 |
| A pilot trial of thymalfasin (thymosin-α-1) to treat hospitalized patients with hypoxemia and lymphocytopenia due to coronavirus disease 2019 infection F Shehadeh, G Benitez, EK Mylona, QL Tran, M Tsikala-Vafea, E Atalla, ... The Journal of infectious diseases 227 (2), 226-235, 2023 | 14 | 2023 |
| Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers C Nugent, Y Abul, EM White, F Shehadeh, M Kaczynski, LO Felix, ... Vaccine 41 (22), 3403-3409, 2023 | 10 | 2023 |
| 80% of patients with COVID-19 have≥ 1 long-term effect at 14 to 110 d after initial symptoms M Kaczynski, E Mylonakis Annals of internal medicine 175 (1), JC10, 2022 | 5 | 2022 |
| Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19 NR Aggarwal, J Nordwall, DL Braun, L Chung, J Coslet, T Der, N Eriobu, ... Clinical Infectious Diseases 78 (6), 1490-1503, 2024 | 2 | 2024 |
| Broad immunogenicity to prior SARS-CoV-2 strains and JN. 1 variant elicited by XBB. 1.5 vaccination in nursing home residents Y Abul, C Nugent, I Vishnepolskiy, T Wallace, E Dickerson, L Holland, ... medRxiv, 2024 | 2 | 2024 |
| Impact of prior HBV, HAV, and HEV infection on non‐alcoholic fatty liver disease S Vassilopoulos, M Kalligeros, A Vassilopoulos, F Shehadeh, G Benitez, ... Journal of Viral Hepatitis 30 (8), 685-693, 2023 | 1 | 2023 |
| Clinical Outcomes Associated with SARS-CoV-2 Co-Infection with Rhinovirus and Adenovirus in Adults—A Retrospective Matched Cohort Study QL Tran, G Benitez, F Shehadeh, M Kaczynski, E Mylonakis International Journal of Environmental Research and Public Health 20 (1), 646, 2022 | 1 | 2022 |
| Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study TO Jensen, TA Murray, GA Grandits, MK Jain, B Grund, K Shaw-Saliba, ... The Lancet Microbe, 2024 | | 2024 |
| Temporal trends and characteristics associated with racial, ethnic, and sex representation in COVID-19 clinical trials: A systematic review and meta-analysis M Kaczynski, A Vassilopoulos, S Vassilopoulos, A Sisti, G Benitez, ... Contemporary Clinical Trials, 107578, 2024 | | 2024 |
| Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19 TO Jensen, GA Grandits, MK Jain, TA Murray, B Grund, K Shaw-Saliba, ... The Journal of infectious diseases 229 (3), 671-679, 2024 | | 2024 |
| Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis A Vassilopoulos, M Kalligeros, S Vassilopoulos, F Shehadeh, G Benitez, ... Digestive Diseases and Sciences 69 (3), 989-1003, 2024 | | 2024 |
| 2509. Association of Non-Alcoholic Fatty Liver Disease with HBV, HAV, and HEV Exposure S Vassilopoulos, A Vassilopoulos, G Benitez, M Kaczynski, F Shehadeh, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2127, 2023 | | 2023 |
| Factors Associated With Enrollment into Inpatient Coronavirus Disease 2019 Randomized Controlled Trials: A Cross-sectional Analysis M Kaczynski, G Benitez, EK Mylona, QL Tran, E Atalla, M Tsikala-Vafea, ... Open Forum Infectious Diseases 10 (5), ofad197, 2023 | | 2023 |
| Effect of thymalfasin (Thymosin-α-1) on reversing lymphocytopenia among patients with COVID-19 G Benitez, F Shehadeh, EK Mylona, QL Tran, M Tsikala-Vafea, E Atalla, ... International Immunopharmacology 116, 109831, 2023 | | 2023 |
Eleftherios MylonakisHouston Methodist Hospital在 houstonmethodist.org 的电子邮件经过验证
